Search

Search bills, members, committees and pages...

CURRAX PHARMACEUTICALS LLC

14 federal lobbying filings, 2023 to 2026.

CURRAX PHARMACEUTICALS LLC is a client on 14 federal lobbying filings, 2023 to 2026, reporting $880K across them. Specialty pharmaceutical business Based in Tennessee.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

1 it has hired, by filings.

RegistrantFilingsReported
DLA PIPER LLP (US)14$880K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262$100K
20254$210K
20244$340K
20234$230K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
PHAPharmacy14

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 4231Treat and Reduce Obesity Act of 20254
S. 1973Treat and Reduce Obesity Act of 20254

Lobbyists

Named on the filings.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
CURRAX PHARMACEUTICALS LLCDLA PIPER LLP (US)2026 second_quarter$50KJul 20, 2026
CURRAX PHARMACEUTICALS LLCDLA PIPER LLP (US)2026 first_quarter$50KApr 20, 2026
CURRAX PHARMACEUTICALS LLCDLA PIPER LLP (US)2025 fourth_quarter$50KJan 20, 2026
CURRAX PHARMACEUTICALS LLCDLA PIPER LLP (US)2025 third_quarter$50KOct 20, 2025
CURRAX PHARMACEUTICALS LLCDLA PIPER LLP (US)2025 second_quarter$50KJul 21, 2025
CURRAX PHARMACEUTICALS LLCDLA PIPER LLP (US)2025 first_quarter$60KApr 21, 2025
CURRAX PHARMACEUTICALS LLCDLA PIPER LLP (US)2024 fourth_quarter$70KJan 21, 2025
CURRAX PHARMACEUTICALS LLCDLA PIPER LLP (US)2024 third_quarter$90KOct 21, 2024
CURRAX PHARMACEUTICALS LLCDLA PIPER LLP (US)2024 second_quarter$90KJul 22, 2024
CURRAX PHARMACEUTICALS LLCDLA PIPER LLP (US)2024 first_quarter$90KApr 19, 2024
CURRAX PHARMACEUTICALS LLCDLA PIPER LLP (US)2023 fourth_quarter$90KJan 22, 2024
CURRAX PHARMACEUTICALS LLCDLA PIPER LLP (US)2023 third_quarter$90KOct 20, 2023
CURRAX PHARMACEUTICALS LLCDLA PIPER LLP (US)2023 second_quarter$50KAug 31, 2023
CURRAX PHARMACEUTICALS LLCDLA PIPER LLP (US)2023 second_quarterAug 30, 2023